911. High human papillomavirus (HPV) vaccination coverage is achievable in patients vaccinated at the school based health center (SBHC).
Session: Oral Abstract Session: Vaccines, Vaccine Preventable Disease, and their Impact
Friday, October 28, 2016: 8:30 AM
Room: 275-277
Background:

HPV vaccination coverage in the Unites States remains low. In 2014, 4 out of 10 girls and 6 out of 10 boys remained unvaccinated. Implementation of the multiple dosing HPV vaccination regimen remains a challenge due to the barriers presented by parents, providers, and an inadequate delivery system. School-based health centers (SBHCs) offer an accessible and convenient setting to deliver adolescent vaccines.

Methods:

We have assessed HPV vaccination coverage through a retrospective review of electronic medical records. We included all patients enrolled in a large SBHC who had vaccination records accessible. The patients were assigned to SBHC, community health center (CHC), or private provider depending on where they received the Tdap vaccine. Bivariate group sub analyses included vaccination series by number of doses, and timeliness of HPV vaccination.

Results:

Vaccination completion (3 doses) was highest for both females and males vaccinated at the SBHC, 81.1% and 67.7%, respectively compared to other sites. SBHC had a significantly higher vaccination coverage rate for both genders compared to CHC and private provider (p<.01) Table 1. In addition, SBHC was more likely to initiate vaccination at a younger age compared to CHC and private provider, Table 2.

Conclusion:SBHCs are ideally suited for the HPV vaccination regimen as they lead to higher coverage for both genders compared to more traditional settings. Larger studies are needed to corroborate our findings to support broader implementation of the HPV vaccination program in SBHCs.

Table 1: HPV vaccination completion by vaccination site and number of doses received.


SBHC

N

HPV1*

HPV2*

HPV3*

Female

37

86.5%

86.5%

81.1%

Male

31

77.4%

74.2%

67.7%

CHC

Female

17

70.6%

64.7%

58.8%

Male

19

84.2%

68.4%

63.2%

PRIVATE

Female

44

45.5%

38.6%

27.3%

Male

25

36.0%

20.0%

16.0%

 *% of patients receiving 1,2 or 3 doses of HPV vaccine

  

Table 2: Age distribution for first dose of HPV vaccine by vaccination site.

SBHC

CHC

Private

Total

N=58

N=28

N=29

<11 years

69.0%

28.6%

3.5%

11-12

27.6%

67.9%

79.3%

13+

3.4%

3.5%

17.2%

Jana Shaw, MD, MPH, FPIDS, Pediatrics, SUNY Upstate Medical University, Syracuse, NY, Mehek Mehta, Ms, SUNY Upstate Medical University, Syracuse, NY and Louise-Anne Mcnutt, PhD, Institute for Health and the Environment, School of Public Health, University at Albany, SUNY, Rensselaer, NY

Disclosures:

J. Shaw, None

M. Mehta, None

L. A. Mcnutt, None

Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.